Humoral and Cellular Immune Response after Three Doses of Sinopharm [Vero Cell]-Inactivated COVID-19 Vaccine in Combination with SARS-CoV-2 Infection Leads to Hybrid Immunity

Humoral and Cellular Immune Response after Three Doses of Sinopharm [Vero Cell]-Inactivated COVID-19 Vaccine in Combination with SARS-CoV-2 Infection Leads to Hybrid Immunity

Background: Several vaccines against COVID-19 have been developed and licensed to enhance the immune response against SARS-CoV-2. Similarly, previous infection with SARS-CoV-2 has been shown to provide significant protection against severe infection and hospitalization. Methods: We investigated the...

Full description

Bibliographic Details
Main Authors: Marija Vukčević, Katarina Šerović, Mateja Despot, Aleksandra Nikolić-Kokić, Aleksandra Vujović, Milan Nikolić, Duško Blagojević, Tanja Jovanović, Dragana Despot
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Pharmaceuticals
Subjects:
COVID-19
Sinopharm vaccine
neutralizing antibodies
anti-S1 IgG antibodies
anti-RBD IgM antibodies
anti-N IgM antibodies
Online Access:https://www.mdpi.com/1424-8247/17/1/122

Similar Items

Similar Items